Fujii Hideki

フジイヒデキ | Fujii Hideki

Affiliation and department：
Job title： Lecturer

Research field (1)： Gastroenterology

Research keywords (5)：脂肪肝炎 , diagnosis , 肝臓 , 線維化 , Hepatocellular carcinoma

Research theme for competitive and other funds (6)：

2017 - 2020 Role of red blood cells and platelets in the development of chronic inflammation of nonalcoholic steatohepatitis
2013 - 2017 Mechanism of formation of hepatic steatosis in Non-alcoholic fatty liver disease (NAFLD)
2011 - 2012 The role of macrophage scavenger receptor in hepatocarcinogenesisbased on steatohepatitis
2009 - 2010 Role of macrophage scavenger receptor A in the progression of dietary steatohepatitis in mice
2006 - 2007 変性赤血球による非アルコール性脂肪性肝炎病態の修飾

Show all

Papers (279)：

角田圭雄, 石破博, 藤井英樹. FOCUS NAFLD診断・治療へのアプローチ-検査はこのように利用されている. 検査と技術. 2024. 52. 4. 420-423
Kozuka R, Enomoto M, Yukawa-Muto Y, Odagiri N, Kotani K, Motoyama H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, et al. Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, et al. Prognosis of biopsy-confirmed MASLD: a sub-analysis of the CLIONE study. Clinical and molecular hepatology. 2024
Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, et al. Accuracy of the enhanced liver fibrosis test in patients with type 2 diabetes mellitus and its clinical implications. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023
藤井英樹. 特集 NASH/NAFLDアップデート:患者数急増時代の実践ガイド総論疫学と予後に関する最新エビデンス. 診断と治療. 2023. 111. 12. 1567-1570

ｍore...

MISC (103)：

藤井英樹. 【NASH/NAFLDアップデート:患者数急増時代の実践ガイド】総論疫学と予後に関する最新エビデンス. 診断と治療. 2023. 111. 12. 1567-1570
藤井英樹. 【肝疾患-診療のチェックポイント2023】(第I部)診断のチェックポイント(第5章) 肝疾患鑑別診断のチェックポイントアルコール性肝炎,非アルコール性脂肪肝炎の診断. 臨床消化器内科. 2023. 38. 7. 831-835
藤井英樹. 【NAFLD/NASHの診断と治療の進歩】NAFLD/NASHの長期予後. Progress in Medicine. 2023. 43. 5. 409-414
藤井英樹, 川中美和, 高橋宏和. 脂肪性肝疾患診療の未来予想図(現状と課題) 血清アルブミン値を用いた肝生検施行NAFLD患者の予後予測~多施設共同研究. 肝臓. 2023. 64. Suppl.1. A43-A43
林秀樹, 鎌田佳宏, 藤井英樹. 肝疾患における画像診断の進歩 FibroScanのLSMおよびCAPを用いたNAFLD患者の肝関連イベント予測多施設共同研究. 肝臓. 2023. 64. Suppl.1. A150-A150

ｍore...

Lectures and oral presentations (201)：

ｍore...

Education (2)：

Professional career (1)：

Work history (12)：

2022/04 - 現在 Osaka Metropolitan University School of Medicine Department of Medical Science Lecturer
2019/07 - 現在 Osaka City University Hospital Department of Premier Preventive Medicine Assistant Professor
2019/04 - 現在 Osaka City University Graduate School of Medicine Clinical Medicine Course Lecturer
2014/04 - 2019/09 Osaka City Juso Hospital Department of Gastroenterology and Hepatology head physician
2019/04 - 2019/06 Osaka Socio-Medical Center Hospital Department of Internal Medicine Chief physician

Show all

Association Membership(s) (3)：

日本肝臓学会 , 日本内科学会 , 日本消化器病学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page